effects [qlco]
Hormone replacement therapy [topp]
Antioxidant [phsu]
Vitamin [orch, phsu, vita]
Supplement [food]
Coronary Atherosclerosis [dsyn]
postmenopausal [tmco]
Women [popg]
randomized controlled trial [inpr, resa]
Context [fndg]
Hormone replacement therapy [topp]
Antioxidant [phsu]
Vitamins [orch, phsu, vita]
Secondary Prevention [topp]
postmenopausal [tmco]
Women [popg]
Coronary Disease [dsyn]
Clinical Trials [resa]
Benefit [qnco]
Support [medd]
Objective [inpr]
Hormone replacement therapy [topp]
Antioxidant [phsu]
Vitamin Supplements (NOS) [orch, phsu, vita]
Alone [qnco]
Combination [qlco]
progression [patf]
coronary artery disease [dsyn]
postmenopausal [tmco]
Women [popg]
Measured [qlco]
serial [inpr, mnob]
Quantitative [qnco]
Coronary angiography [diap]
Design [acty]
setting [ftcn]
Patients [podg]
Women [popg]
Angiographies [diap]
Vitamin [orch, phsu, vita]
Estrogen [horm, phsu, strd]
wave [npop]
Trial [resa]
randomized [resa]
DOUBLE BLIND [resa]
Trial [resa]
postmenopausal [tmco]
Women [popg]
Coronary Stenosis [dsyn]
baseline [bodm]
Coronary angiography [diap]
Trial [resa]
Conduct [inbe]
Clinical Center [orgt]
United States [geoa]
Canada [geoa]
interventions [hlca]
Patients [podg]
Assigned [ftcn]
FACTORIAL [resa]
Design [acty]
Receive [qlco]
mg/d [qnco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
mg/d [qnco]
medroxyprogesterone acetate [horm, phsu, strd]
Women [popg]
Hysterectomy [topp]
MATCHING [resa]
placebo [topp]
IU [qnco]
Vitamin E [lipd, phsu, vita]
Twice daily [tmco]
mg% [qnco]
Vitamin C [orch, phsu, vita]
Twice daily [tmco]
placebo [topp]
Main [qlco]
outcome measure [qnco]
Minimum [qlco]
Lumen Diameter [qnco]
baseline [bodm]
conclude [bodm, orch]
angiogram [diap]
Qualifying [qlco]
Coronary Lesion [fndg]
Average [qnco]
Patients [podg]
Myocardial Infarction [dsyn]
Imputed [qnco]
Worst [qlco]
Rank [inpr]
Angiographies [diap]
Interval [tmco]
angiograms [diap]
coronary [bpoc]
progression [patf]
Measured [qlco]
worsened [fndg]
Hormone replacement therapy [topp]
Hormone replacement therapy [topp]
placebo [topp]
P NOS [aapp, imft]
Antioxidant [phsu]
Vitamins [orch, phsu, vita]
Vitamin [orch, phsu, vita]
placebo [topp]
P-32 [irda, orch, phsu]
Patients [podg]
Myocardial Infarction [dsyn]
included [ftcn]
Primary [qlco]
Increased [qnco]
Women [popg]
Active [ftcn]
Hormone replacement therapy [topp]
Group [idcn]
P NOS [aapp, imft]
Suggest [idcn]
Increased [qnco]
Active [ftcn]
Vitamin [orch, phsu, vita]
Group [idcn]
P NOS [aapp, imft]
Patients [podg]
Died [orgf]
Hormone replacement therapy [topp]
Group [idcn]
Hormone replacement therapy [topp]
placebo [topp]
Group [idcn]
Hazard Ratio [qnco]
Vitamin [orch, phsu, vita]
Group [idcn]
Vitamin [orch, phsu, vita]
placebo [topp]
Group [idcn]
Hazard Ratio [qnco]
Myocardial Infarction [dsyn]
Stroke [dsyn]
Occurred [acty]
Hormone replacement therapy [topp]
Patients [podg]
Hormone replacement therapy [topp]
Hazard Ratio [qnco]
Vitamin [orch, phsu, vita]
Patients [podg]
Vitamin [orch, phsu, vita]
Hazard Ratio [qnco]
Interaction [ftcn]
treatment [ftcn]
interventions [hlca]
postmenopausal [tmco]
Women [popg]
Coronary Disease [dsyn]
Hormone replacement therapy [topp]
Antioxidant [phsu]
Vitamin Supplements (NOS) [orch, phsu, vita]
CARDIOVASCULAR [bdsy]
Benefit [qnco]
Suggest [idcn]
treatment [ftcn]
